U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436221) titled 'A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma' on Feb. 03.
Brief Summary: This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK139 in the treatment of participants with moderate to severe asthma.
Study Start Date: Feb. 28
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
DRUG: AK139
AK139 regimen 1- subcutaneous injection.
DRUG: AK139
AK139 regimen 2- subcutaneous injection.
DRUG: AK139
AK139 regimen 3- subcutaneous injection.
DRUG: Placebo
subcutaneous injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Akeso
Published ...